Grants and Contributions

The specific objectives of this funding opportunity are:
• To provide recognition and funding to academic researchers;
• To provide a reliable supply of highly skilled and qualified researchers.

• CIHR-IG will provide funding for applications that are determined to be relevant to its mandate:
o The Institute of Genetics (IG) supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries

• CIHR-IG will provide funding for applications that are determined to be relevant to its mandate:
o The Institute of Genetics (IG) supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries

• CIHR-IG will provide funding for applications that are determined to be relevant to its mandate:
o The Institute of Genetics (IG) supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries

• CIHR-IG will provide funding for applications that are determined to be relevant to its mandate:
o The Institute of Genetics (IG) supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries

• The CIHR Institute of Human Development, Child and Youth Health (CIHR-IHDCYH), will provide bridge funding for an application by an early-career researcher that is relevant to the Institute's mandate:
o As a lifecycle-based Institute, IHDCYH has a broad mandate that covers defined time periods and a wide range of issues pertaining to human development: pre-conception; fertilization; embryonic and fetal development; the health of the mother and father; and the health and development of infants, children and youth.
• Bridge funding can be used at the NPAs discretion to catalyze work on their proposed project in the manner they feel best moves forward their research program, for example, collection of pilot data, demonstration of feasibility, or work to address peer review comments.

• The CIHR Institute of Human Development, Child and Youth Health (CIHR-IHDCYH), will provide bridge funding for an application by a mid-career researcher that is relevant to the Institute's mandate:
o As a lifecycle-based Institute, IHDCYH has a broad mandate that covers defined time periods and a wide range of issues pertaining to human development: pre-conception; fertilization; embryonic and fetal development; the health of the mother and father; and the health and development of infants, children and youth.
• Bridge funding can be used at the NPAs discretion to catalyze work on their proposed project in the manner they feel best moves forward their research program, for example, collection of pilot data, demonstration of feasibility, or work to address peer review comments.

• The CIHR Institute of Human Development, Child and Youth Health (CIHR-IHDCYH), will provide bridge funding for an application by a mid-career researcher that is relevant to the Institute's mandate:
o As a lifecycle-based Institute, IHDCYH has a broad mandate that covers defined time periods and a wide range of issues pertaining to human development: pre-conception; fertilization; embryonic and fetal development; the health of the mother and father; and the health and development of infants, children and youth.
• Bridge funding can be used at the NPAs discretion to catalyze work on their proposed project in the manner they feel best moves forward their research program, for example, collection of pilot data, demonstration of feasibility, or work to address peer review comments.

• The CIHR Institute of Infection and Immunity (CIHR-III) will fund applications that are determined to be specifically relevant to their mandate with a primary focus on biomedical research in which the objective and aims are directed towards building foundational knowledge in immunology and/or infectious diseases. This priority announcement will prioritize funding for research in the following research areas:
o Infection:
¿ Zoonotic or vector-borne transmission of pathogens in the context of Global Climate Change;
¿ Understanding functional genomics and/or molecular epidemiology of emerging/re-emerging pathogens;
¿ Resistance to fungal infections and/or the role of bacteriophages in combatting antimicrobial resistance (AMR).
o Immunity:
¿ Immune mechanisms involved in the development of trained innate immunity;
¿ Immune mechanisms involved in the development and maintenance of tissue-specific immunity;
¿ Metabolic regulation of immune cells and processes (immunometabolism).
• Should there be no eligible applications relevant to the research areas identified above, III will fund applications that are relevant to its mandate with a primary focus on biomedical research in which the objective and aims are directed towards building foundational knowledge in immunology and/or infectious diseases.

• The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications that are determined to be relevant to its mandate and research priority areas as described below:
o IMHA Mandate:
¿ IMHA is mandated to provide research leadership related to: active living, mobility and the wide range of conditions related to bones, joints, muscles, connective tissue, skin as well as the mouth, teeth and craniofacial region.
o Research Priority Areas:
¿ Myalgic Encephalomyelitis (ME)
¿ Pain
¿ Oral Health